![Meningococcal Conjugate Vaccine | Menactra® (Meningococcal [Groups A, C, Y, and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine)](https://www.menactra.com/_assets/img/menactra-web-timeline-art-mobile.jpg "Meningococcal Conjugate Vaccine | Menactra® (Meningococcal [Groups A, C, Y, and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine)")
Meningococcal Conjugate Vaccine | Menactra® (Meningococcal [Groups A, C, Y, and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine)
![MENVEO (Meningococcal [Groups A,C,Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) | Home](https://gskpro.com/content/dam/global/hcpportal/en_US/img/menveo/hero-mobile-image.png "MENVEO (Meningococcal [Groups A,C,Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) | Home")
MENVEO (Meningococcal [Groups A,C,Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) | Home
Participant flow. (ACWY-TT = children who received a dose of MenACWY-TT... | Download Scientific Diagram
For Providers — Meningitis B Action Project
Meningococcal Vaccination | CDC
Meningococcal vaccination for people in a special risk group | The Australian Immunisation Handbook
Meningitis booster vaccine now required for high school seniors | News | wataugademocrat.com
ACIP provides recommendations on meningococcal vaccination
A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years | BMC Infectious Diseases
Meningococcal Serogroup A, C, W135 and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands | PLOS ONE
MenACWY Updates: Give 2 Doses to Strengthen Adolescents Immunizations - CPP | National Vaccine Buying Group | Vaccine Group Purchase Organization
ACIP recommendations for COVID-19 vaccines—and more | MDedge Family Medicine
MenACWY Frenquently Asked Questions - HSE.ie
A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years | BMC Infectious Diseases
ACIP Updates Recommendations for Meningococcal Vaccination | AAFP
Teens & Young Adults Archives - Page 2 of 4 - Unity Consortium
Meningococcal Disease — Kimberly Coffey Foundation
Adolescent Vaccination
Immunisation for teenagers between 14 and 18 years old | nidirect
Dosing & Infusion Instruction | Soliris® (eculizumab) HCP
Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children - ScienceDirect
Antibody persistence and booster response following MenACWY-CRM vaccination in children as assessed by two different assay methods - ScienceDirect
Meningococcal Vaccine Toolkit | IKC
Schedule for Booster Doses in | Download Table
A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years | BMC Infectious Diseases
Univariate sensitivity analysis for MenACWY + MenACWY compared with... | Download Scientific Diagram
